🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Excellent discussion by Clint Cary, MD MPH MBA #GU25 following Axel Heidenreich’s long term followup of COTRIMS trial. Surgery for early metastatic seminoma. Appreciate continuous efforts to improve on already excellent curative outcomes with #RPLND alone. #SEMS. Testicular Cancer Society Testicular Cancer

Addressing cognitive decline in #BladderCancer patients through prehab and rehab. Sarah P. Psutka MD MS Fred Hutch Cancer Center joins Zach Klaassen Georgia Cancer Center to share how treatments can impact cognitive function, affecting up to 1/3 of patients and highlights strategies like brain training,

What a fun and insightful first ASCO #GU25! Learned a ton and already looking forward to next year. Huge shoutout to Hedyeh Ebrahimi! Outstanding work, truly worthy of the Conquer Cancer, the ASCO Foundation Merit Award & your name alongside the best in the field. Super proud, Sis!

My amazing sister🤩 BIDMC IM Residency just got one ⭐️! Beyond proud of you, Hedyeh Ebrahimi🥳 #Match2025

I started working with Hedyeh Ebrahimi almost 3 years ago. She hit the ground running with a beautiful oral presentation at #ASCO23. No small feat to do a talk in front of a massive ASCO audience as a new member of the team, but even more impressively, she followed up this

Delighted to share our new paper on UTUC 📊 883 pts (15% NAC) from ROBUUST 2.0 🚨 ypN+: worse 5yr OS vs. pN+ (20% vs. 31%) 📉 All ypN+ had mets at 1yr, 13% pN+ mets-free 🔄 Recurrence patterns vary by nodal/NAC 🔗authors.elsevier.com/c/1kpgh3r93ngf… Dr. Hooman Djaladat USC Urology Urologic Oncology

Happening now: An all 🌟 panel of experts is sharing insights on precision medicine and the evolving landscape of bladder cancer care at #AUA2025 Sia Daneshmand, M.D. Laura Bukavina Sarah P. Psutka MD MS Matt Galsky PeerView Bladder Cancer Advocacy Network

Compelling presentation by Dr. Hooman Djaladat #AUA2025 on the ongoing phase 3 trial assessing effect of vesicopexy on urinary continence and quality of life after robotic radical prostatectomy. 📊Preliminary data is out! Findings are promising. Farshad Sheybaee Moghaddam Alireza Ghoreifi, MD

🚀 New Advanced Urology Updates webcast on #SIUAcademy: Robotic-Assisted RPLND. Dr Hooman Djaladat shares expert surgical techniques to optimize oncological outcomes for advanced germ cell tumour treatment. Learn best practices for RP mass node dissection in complex, real-world

Outcomes of Minimally Invasive Nephrectomy Following Immune-Checkpoint Inhibitor Therapy: A Multicenter Propensity Score-Matched Analysis - Beyond the Abstract UroToday.com Dr. Hooman Djaladat 🔗tinyurl.com/37r2dn5y